Andrx Receives First Generic Approval For Abbott's Biaxin XL
This article was originally published in The Pink Sheet Daily
Executive Summary
The generic firm does not plan to market clarithromycin extended-release 500 mg tablets until expiration of Abbott's compound patent in May 2005. Abbott says the XL formulation is patented through 2017.